-
Entity
-
Individual
-
Location
-
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, California
-
Summary
-
The estimated net worth of Camille L. Bedrosian is at least $4.45 M dollars as of June 25, 2024. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $2.91 M. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981 K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446 K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $117 K.